11 people shaping psychedelics drug development

It's widely believed that Compass will be the first psychedelics company to win regulatory approval in the U.S.

September 17, 2024 Check out STAT+

Sponsored By

John Moore/Getty Images STAT+ | 11 people shaping psychedelics drug development A new STAT profile series looks at movers and shakers in various fields. First up: psychedelics, an industry now in both transformation and flux. By Meghana Keshavan STAT+ | What pharma companies and insurers think about Medicare's plan to cover digital treatments Developers of digital treatments have been lobbying for Medicare coverage for years as it could prompt reimbursement by commercial insurers. By Mario Aguilar A documentary film asks: Can health systems improve patient safety by embracing new tech? "The Pitch" spotlights how a new generation of technology stands to improve patient safety in the United States. By Casey Ross Kevin Dietsch/Getty Images STAT+ | Express Scripts sues FTC over a 'biased' report about pharmacy benefit managers The company wants the agency's "unlawful report" to be vacated and says it should "take steps" to correct the "false statements" made about PBMs. By Ed Silverman STAT+ | Most cardiovascular devices with serious safety recalls aren't tested in patients The new data comes as a government watchdog is looking into how the FDA authorizes medical devices and handles safety recalls. By Katie Palmer STAT+ | Democrats keep IVF in the spotlight with another Senate vote Senate Majority Leader Chuck Schumer wants to put Republicans on the defensive. Sign up for STAT's twice-weekly newsletter about the politics and policy of health and medicine. By Sarah Owermohle A history of mpox so far Your questions answered on mpox, a viral outbreak designated a public health emergency of international concern (PHEIC) by the World Health Organization. By Hyacinth Empinado and Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser